Plasma Tumor Mutation Burden and Response to Pembrolizumab-Letter. Xue Z, Guo X, Wen J, Cai W, et al. Clin Cancer Res 2021;27:1580.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Xue Z, Guo X, Wen J, Cai W, et al. Plasma Tumor Mutation Burden and Response to Pembrolizumab-Letter. Clin Cancer Res 2021;27:1580.
PMID: 33649190